DIETARY COMPOSITIONS COMPRISING DOCOSAHEXAENOIC ACID AND EICOSAPENTAENOIC ACID AND USE THEREOF FOR TREATING INSULIN RESISTANCE

摘要

The invention relates to formulations of nutritional supplements, and methods for administering those supplements to alter an insulin level, to treat insulin resistance, and/or to treat obesity in a patient in need thereof. The nutritional supplement includes (a) docosahexaenoic acid (DHA), (b) eicosapentaenoic acid (EPA), and (c) optionally, a specific inhibitor of enzyme delta-5 desaturase (D5D).